Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy.
D000328:Adult; D000609:Aminoacridines / Q000008:administration & dosage / Q000633:toxicity*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000633:toxicity*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D012640:Seizures / Q000139:chemically induced*; D014693:Ventricular Fibrillation / Q000139:chemically induced*
D000609:Aminoacridines; D000970:Antineoplastic Agents